Radiolabeled peptide

This page covers all Radiolabeled peptide drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting PSMA.

Targets

PSMA

Phase 2 pipeline (1)

• 177Lu-DOTA-TLX591 · Telix Pharmaceuticals (Innovations) Pty Limited · Oncology
  177Lu-DOTA-TLX591 is a radiolabeled peptide that targets the prostate-specific membrane antigen (PSMA) for targeted alpha-particle therapy.